<DOC>
	<DOCNO>NCT01221740</DOCNO>
	<brief_summary>1 . To show patient great pain sensitivity show great improvement symptom ( self-reported pain intensity , mood , sleep , quality life ) low pain sensitivity , base QST , take milnacipran . 2 . To compare outcome difference ( pain intensity , mood , activity interference , sleep , side effect ) patient either take take opioids pain 10 week prescribe milnacipran . 3 . To show patient old , male , medical comorbidities , great disability , long pain duration report less improvement ( pain , mood , sleep , health-related quality life ) treatment satisfaction take milnacipran compare others without characteristic .</brief_summary>
	<brief_title>Pain Assessment Quality Life Back Pain Patients : Role Milnacipran</brief_title>
	<detailed_description>Chronic pain costly syndrome influence every aspect patient 's life . Significant interference sleep , employment , social functioning , daily activity common . Chronic pain patient frequently report depression , anxiety , irritability , sexual dysfunction , decrease energy . Family roles alter , worry abound financial limitation future consequence restrict lifestyle . Epidemiological study independently document chronic pain immense international problem . Chronic pain symptom afflict one third American population ( 80 million people ) . Chronic pain account 21 % emergency room visit 25 % annual missed work day . When direct indirect cost consider , chronic pain imposes great economic burden disease , annual estimate $ 100 billion . Patients complete number questionnaire baseline undergo quantitative sensory testing ( QST ) well complete handheld electronic diary PDA throughout entire 10 week study . Patients evaluate physician receive complete history physical . Radiological study consult confirm diagnosis . All subject consent participate study start convert milnacipran currently take SSRI , buproprion , TCA . This do 1 2 week period gradually wean antidepressant escalate milnacipran . All adjuvant medication remain constant course 10-week trial . Efforts make recruit least 40 % patient ( N= 24 ) take opioids pain . At end study , patient repeat baseline questionnaire list except demographic questionnaire . They also ask complete Treatment Helpfulness Questionnaire . We compare secondary outcome difference ( treatment satisfaction helpfulness ) patient either opioids .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>18 year old Primary diagnosis spinal pain least 6 month ' duration Average pain intensity score 4 great Current diagnosis cancer malignant disease Acute bone disease History DSMIV psychotic disorder Pregnancy Any illness judge PI interfere treatment Any acute condition require surgery Currently take SNRI MAOI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>To show patient great pain sensitivity</keyword>
	<keyword>show great improvement symptom</keyword>
	<keyword>( self-reported pain intensity , mood , sleep ,</keyword>
	<keyword>quality life ) low pain</keyword>
	<keyword>sensitivity , base QST , take milnacipran .</keyword>
	<keyword>To compare outcome difference</keyword>
	<keyword>( pain intensity , mood , activity interference ,</keyword>
	<keyword>sleep , side effect ) patient</keyword>
	<keyword>either take taking opioids</keyword>
	<keyword>pain 10 week prescribe milnacipran .</keyword>
	<keyword>To show patient old , male ,</keyword>
	<keyword>medical comorbidities , great disability ,</keyword>
	<keyword>longer pain duration report less improvement</keyword>
	<keyword>( pain , mood , sleep , health-related quality life )</keyword>
	<keyword>treatment satisfaction take milnacipran</keyword>
	<keyword>compare others without characteristic .</keyword>
	<keyword>identify patient back neck pain</keyword>
	<keyword>great 6 month</keyword>
	<keyword>QST</keyword>
	<keyword>10 week</keyword>
	<keyword>milnacipran</keyword>
	<keyword>pain intensity</keyword>
	<keyword>mood</keyword>
	<keyword>activity</keyword>
	<keyword>interference</keyword>
	<keyword>sleep</keyword>
	<keyword>side effect</keyword>
	<keyword>age</keyword>
	<keyword>gender</keyword>
	<keyword>medical comorbidities</keyword>
	<keyword>pain diagnosis</keyword>
	<keyword>pain duration</keyword>
	<keyword>disability status</keyword>
</DOC>